Positive data published for Jakavi in chronic GvHD
July 15, 2021Incyte and Novartis have announced the publication of positive data from Phase III trials in NEJM, demonstrating Jakavi (ruxolitinib) significantly …
New targeted lung cancer treatment coming to UK under MHRA scheme
July 15, 2021MHRA, NSCLC, UK, brexit
The MHRA has issued an Early Access to Medicines Scheme (EAMS) positive scientific opinion for tepotinib, for the treatment of …
Lethal triple mix of winter viruses could “push NHS to breaking point”
July 15, 2021COVID-19, NHS, influenza
A report from the Academy of Medical Sciences has found that a lethal triple mix of COVID-19, influenza, and the …
First ever human implant of fully artificial heart announced
July 15, 2021cardiovascular
CARMAT has announced that the first ever human implantation of their fully artificial heart, which was designed as a therapeutic …
US starts national Medicare review for Biogen’s Alzheimer’s drug
July 14, 2021Research and Development
The US government has started a review process for national Medicare coverage of Biogen’s controversial Alzheimer’s drug, Aduhelm, that was …
Study finds 40% of severe COVID infections following double jabs are immocompromised
July 14, 2021An Israeli study looking at those who have contracted COVID following double vaccination with the Pfizer jab, has found that …
AstraZeneca gets green light for £27.5bn Alexion acquisition
July 14, 2021Research and Development
AstraZeneca has been given the green light of its $39 billion buyout of US-based rare diseases business Alexion by the …
NHS: Cancer backlog to be cleared by March 2022
July 14, 2021Research and Development
NHS chiefs have announced plans to clear the backlog of cancer patients caused by the pandemic by March 2022. Due …
Half the world oblivious to link between oral hygiene and overall health
July 14, 2021Research and Development
A new study from GSK’s consumer healthcare business and Ipsos has shown that half of the world (49%) doesn’t know …
New warning added to J&J vaccine in US
July 13, 2021Manufacturing and Production COVID-19, FDA, J&J, JJ, US, Vaccine
The FDA has made the decision to add a warning to the fact sheet for Johnson & Johnson’s COVID-19 vaccine, …
Scientists develop pain-free ‘holy grail’ sugar test for diabetics
July 13, 2021Manufacturing and Production
Scientists in Australia have developed a non-invasive strip that checks glucose levels through saliva that they say is the ‘holy …
Spanner in the works for Sputnik V as missing data reported
July 13, 2021Manufacturing and Production COVID-19, EMA, Russia, Vaccine
Developers of Russia’s Sputnik V COVID-19 vaccine have repeatedly failed to present data to regulators, Reuters has reported. Five sources …
Scotland approves three new medicines
July 13, 2021Manufacturing and Production
The SMC has approved three new medicines; atezolizumab to treat adult patients with advanced hepatocellular carcinoma (HCC, a type of …
Biogen announces collaboration on novel MS treatment
July 13, 2021Manufacturing and Production multiple sclerosis
Biogen and InnoCare Pharma have announced a license and collaboration agreement for orelabrutinib, an oral small molecule Bruton’s tyrosine kinase …
WHO official condemns lack of masks at Euro finals
July 12, 2021Sales and Marketing
WHO COVID-19 technical lead, Maria Van Kerkhove, has condemned the lack of masks and social distancing at last night’s Euro …
Long COVID: Test may be available within six months
July 12, 2021Sales and Marketing
Researchers from Imperial College London have detected rogue antibodies in the blood of long COVID sufferers, which could lead to …
Janssen & Vor Biopharma to collaborate on acute myeloid leukemia treatment
July 12, 2021Sales and Marketing
Vor Biopharma and Janssen have announced a collaboration to develop engineered hematopoietic stem cell transplants combined with a bi-specific antibody …
FDA acting commissioner seeks review of controversial Alzheimer’s drug approval
July 12, 2021Sales and Marketing
The FDA’s acting commissioner Janet Woodcock is asking for a federal investigation of doctors within her own agency who met …
New data demonstrates extensive activity of Shionogi’s antibiotic cefiderocol
July 12, 2021Sales and Marketing
Shionogi’s novel antibiotic, cefiderocol, has extensive in vitro activity against some of the most difficult to treat carbapenem-resistant Gram-negative bacteria.The …
NICE rejects gene therapy for children with neurodegenerative disorder
July 9, 2021Medical Communications
NICE does not recommend gene therapy OTL-200 (also called Libmeldy and made by Orchard Therapeutics) for treating children with the …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
